PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 4, 2025Biomedicines5 citationsOpen Access

Xanthium strumarium L. Exhibits Potent Antiplatelet and Antithrombotic Effects by Modulating MAPK and PI3K/AKT Signaling Pathways and Inhibiting Ferric Chloride-Induced Thrombosis

View Full Paper
AAAbdul Wahab AkramGLGa-Hee LeeSBSu-Min Baek

Key Points

  • Xanthium strumarium shows significant antiplatelet effects by inhibiting thrombosis and enhancing blood flow in murine thrombus models.
  • Key findings revealed reductions in platelet aggregation and preserved morphology through scanning electron microscopy.
  • The study utilized both in vitro and in vivo assessments to evaluate the impact on thrombus formation and signaling pathways.
  • These findings highlight the therapeutic potential of Xanthium strumarium for managing cardiovascular diseases associated with thrombosis.

Abstract

Background: Cardiovascular diseases, driven by platelet hyperactivation and thrombosis, remain the leading global cause of death. Excessive platelet activation contributes to atherosclerosis and thrombo-inflammatory disorders, underscoring the urgent need for safer and more effective antiplatelet agents. Objectives:Xanthium strumarium L. (X. strumarium) has been reported to exhibit a wide range of pharmacological effects, including anti-inflammatory and antioxidant activities. However, its antiplatelet and antithrombotic effects remain unexplored. Therefore, the present study aimed to comprehensively evaluate the antiplatelet and antithrombotic effects of X. strumarium through integrated in vitro and in vivo experiments. Methods: The principal bioactive compounds present in the X. strumarium extract were identified through GC–MS analysis. In vitro antiplatelet effects were evaluated via light transmission aggregometry, scanning electron microscopy (SEM), ATP and calcium mobilization assays, αIIbβ3 binding assay, clot retraction assay, and Western blotting. In vivo ferric chloride-induced (FeCl3) murine thrombus model was established to evaluate thrombogenesis. Results: Our results demonstrated that X. strumarium at 25, 50, or 100 μg/mL significantly inhibited collagen, ADP, U46619, and thrombin-induced platelet aggregation. SEM revealed that X. strumarium pretreatment markedly preserved the resting platelet morphology and inhibited collagen-induced activation and shape changes. Further, the granule secretion, integrin-αIIbβ3 signaling, and the MAPK and PI3K/Akt pathways were also concentration-dependently inhibited. The in vivo blood flow rate and mice survival were improved, and H&E staining further revealed a concentration-dependent prevention of arterial occlusion following X. strumarium treatment. Conclusions: Collectively, X. strumarium demonstrated potent antiplatelet and antithrombotic effects, improving blood flow and survival while preventing arterial occlusion.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Akram et al. (2025) studied this question.

synapsesocial.com/papers/6930e8d7ea1aef094cca3b7fhttps://doi.org/10.3390/biomedicines13122924
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Antiplatelet Effect of Catechol Is Related to Inhibition of Cyclooxygenase, Reactive Oxygen Species, ERK/p38 Signaling and Thromboxane A2 Production2014 · 51 citations
  2. 2Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt22004 · 199 citations
  3. 3Pharmacological actions of dieckol on modulation of platelet functions and thrombus formation via integrin αIIbβ3 and cAMP signaling2022 · 13 citations
  4. 4Poly(Glycerol) Microparticles as Drug Delivery Vehicle for Biomedical Use2023 · 5 citations
  5. 5Structure-Based Cyclic Glycoprotein Ibα-Derived Peptides Interfering with von Willebrand Factor-Binding, Affecting Platelet Aggregation under Shear2022 · 17 citations